Nu Skin Enterprises, Inc. (NUS) Expected to Announce Earnings of $1.17 Per Share

Analysts expect Nu Skin Enterprises, Inc. (NYSE:NUS) to report earnings of $1.17 per share for the current fiscal quarter, Zacks Investment Research reports. Two analysts have provided estimates for Nu Skin Enterprises’ earnings, with estimates ranging from $1.10 to $1.21. Nu Skin Enterprises reported earnings of $0.79 per share in the same quarter last year, which indicates a positive year over year growth rate of 48.1%. The firm is scheduled to report its next earnings report after the market closes on Thursday, February 15th.

According to Zacks, analysts expect that Nu Skin Enterprises will report full year earnings of $3.24 per share for the current year, with EPS estimates ranging from $3.23 to $3.24. For the next financial year, analysts anticipate that the company will post earnings of $3.64 per share, with EPS estimates ranging from $3.39 to $4.11. Zacks’ EPS averages are a mean average based on a survey of sell-side analysts that follow Nu Skin Enterprises.

Nu Skin Enterprises (NYSE:NUS) last announced its quarterly earnings results on Wednesday, November 1st. The company reported $0.76 EPS for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.76. The company had revenue of $563.70 million during the quarter, compared to analyst estimates of $562.70 million. Nu Skin Enterprises had a return on equity of 22.38% and a net margin of 6.97%. The firm’s revenue was down 6.7% on a year-over-year basis. During the same period in the prior year, the firm posted $0.98 earnings per share.

A number of research firms have recently issued reports on NUS. Citigroup reiterated a “buy” rating and issued a $81.00 target price (up previously from $70.00) on shares of Nu Skin Enterprises in a research note on Tuesday. ValuEngine upgraded Nu Skin Enterprises from a “hold” rating to a “buy” rating in a research note on Sunday, December 31st. Finally, Zacks Investment Research upgraded Nu Skin Enterprises from a “sell” rating to a “hold” rating and set a $78.00 target price for the company in a research note on Saturday, December 30th. Two equities research analysts have rated the stock with a sell rating, three have assigned a hold rating and five have given a buy rating to the company’s stock. The stock currently has a consensus rating of “Hold” and a consensus price target of $65.38.

In other news, Chairman Steven Lund sold 13,978 shares of the stock in a transaction dated Friday, January 19th. The stock was sold at an average price of $70.01, for a total value of $978,599.78. Following the completion of the sale, the chairman now owns 4,769 shares in the company, valued at $333,877.69. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, President Ryan S. Napierski sold 11,667 shares of the stock in a transaction dated Wednesday, November 1st. The shares were sold at an average price of $63.84, for a total value of $744,821.28. Following the completion of the sale, the president now owns 71,634 shares of the company’s stock, valued at approximately $4,573,114.56. The disclosure for this sale can be found here. In the last quarter, insiders sold 257,645 shares of company stock valued at $17,367,125. Insiders own 5.20% of the company’s stock.

Hedge funds and other institutional investors have recently modified their holdings of the business. Cerebellum GP LLC acquired a new stake in Nu Skin Enterprises during the 4th quarter valued at approximately $124,000. Migdal Insurance & Financial Holdings Ltd. acquired a new stake in Nu Skin Enterprises during the 3rd quarter valued at approximately $148,000. Dynamic Technology Lab Private Ltd acquired a new stake in Nu Skin Enterprises during the 3rd quarter valued at approximately $219,000. Shelton Capital Management acquired a new stake in Nu Skin Enterprises during the 2nd quarter valued at approximately $232,000. Finally, Quantbot Technologies LP acquired a new stake in Nu Skin Enterprises during the 3rd quarter valued at approximately $229,000. Hedge funds and other institutional investors own 77.52% of the company’s stock.

Nu Skin Enterprises (NYSE:NUS) traded up $1.22 during mid-day trading on Tuesday, hitting $72.06. The stock had a trading volume of 369,242 shares, compared to its average volume of 343,549. The company has a current ratio of 1.78, a quick ratio of 1.18 and a debt-to-equity ratio of 0.44. Nu Skin Enterprises has a fifty-two week low of $47.10 and a fifty-two week high of $72.24. The firm has a market capitalization of $3,790.00, a price-to-earnings ratio of 26.40, a P/E/G ratio of 2.26 and a beta of 1.55.

WARNING: This piece of content was reported by American Banking News and is the property of of American Banking News. If you are accessing this piece of content on another domain, it was copied illegally and reposted in violation of US and international copyright and trademark legislation. The original version of this piece of content can be viewed at https://www.americanbankingnews.com/2018/01/23/nu-skin-enterprises-inc-nus-expected-to-announce-earnings-of-1-17-per-share.html.

About Nu Skin Enterprises

Nu Skin Enterprises, Inc is a direct selling company that develops and distributes personal care products and nutritional supplements, and a range of other products and services. The Company offers anti-aging personal care products and nutritional supplements under its Nu Skin and Pharmanex brands. The Nu Skin brand offers a range of products, including ageLOC Me customized skin care system, ageLOC Spa systems and ageLOC Transformation anti-aging skin care system.

Get a free copy of the Zacks research report on Nu Skin Enterprises (NUS)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply